Pharmaceutical Executive
How low-cost drugs can succeed in the specialty pharmacy channel.
Charlie Bell
Advertisement
Articles by Charlie Bell
Advertisement
Latest Updated Articles
The ‘Spare-No-Expense’ AlternativeSeptember 13th 2018
Advertisement
Advertisement
Trending on PharmExec
1
Trump Administration Adds Nine Drugmakers to Most-Favored-Nation Program: Report
2
Simcere Zaiming Licenses Sim0660 to Roche for $1.53 billion
3
GSK Advances mRNA Flu Vaccine to Phase III
4
Beyond Traditional Strategy Consulting Firms: Why MBA Students Should Consider Turnaround, Restructuring Consulting
5